Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· HRH.R. 2496 (119th)referred
United States · United States Congress · 31 March 2025
Dairy Nutrition Incentive Program Act of 2025 This bill directs the Department of Agriculture (USDA) to establish a dairy nutrition incentive program to develop and test methods to increase the purchase and consumption of dairy under the Supplemental Nutrition Assistance Program (SNAP). Specifically, the program must provide an incentive to SNAP benefit recipients for the purchase of naturally nutrient-rich dairy, which the bill defines to include fluid milk, yogurt, and cheese made from cow's milk. To carry out the program, USDA must enter into cooperative agreements with, or provide competitive grants to, state or local governments and nonprofit organizations for projects. The bill provides funding for the program for each fiscal year. USDA must provide for an independent evaluation of each project that measures, to the maximum extent practicable, the effect of incentives on purchases of naturally nutrient-rich dairy by SNAP recipients. Projects currently carried out by the USDA Healthy Fluid Milk Incentives (HFMI) program must be transitioned to the new dairy nutrition incentive program; the bill repeals the HFMI program one year after USDA certifies that the transition is complete.
Bill· HRH.R. 2497 (119th)referred
United States · United States Congress · 31 March 2025
Bill· HRH.R. 2502 (119th)referred
United States · United States Congress · 31 March 2025
Bill· HRH.R. 2511 (119th)referred
United States · United States Congress · 31 March 2025
Sarah Katz Caffeine Safety Act This bill establishes labeling and disclosure requirements for caffeinated food, beverages, and supplements. Specifically, the bill requires foods and dietary supplements that contain more than 10 milligrams of caffeine to be labeled with (1) their total caffeine content, (2) a statement of whether the caffeine is naturally occurring or is an additive, and (3) an advisory statement indicating that the recommended daily limit of caffeine for healthy adults is 400 milligrams. Further, in restaurant chains with 20 or more locations, menus must indicate that an item contains high caffeine where the item contains added caffeine and has a total caffeine content of at least 150 milligrams. Restaurants must place the statement “high caffeine” or a similar indication adjacent to the name of a covered item on the menu. This requirement applies to both standard and temporary menu items. For standard menu items, the bill also expands the nutritional information that restaurants must make available to consumers in written form to include the number of milligrams of caffeine in an item. The Food and Drug Administration (FDA) must review the safety of caffeine and other stimulants in food, beverages, and dietary supplements and determine whether caffeine should be generally recognized as safe (GRAS) for healthy adults. (Currently, the FDA considers caffeine as GRAS for cola beverages up to a level of 0.02%.) Finally, the Government Accountability Office must study and report to Congress on the marketing of caffeinated beverages in restaurants, stores, and online.
Bill· HRH.R. 2487 (119th)referred
United States · United States Congress · 31 March 2025
Bill· HRH.R. 2527 (119th)referred
United States · United States Congress · 31 March 2025
Bill· HRH.R. 2509 (119th)referred
United States · United States Congress · 31 March 2025
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care or the COMPLETE Care Act This bill increases payments and establishes certain requirements to support integrated behavioral health services under Medicare. Specifically, the bill increases payments for integrated behavioral health services that are provided by physicians under Medicare for 2027-2029, with payments increased by 175% in 2027, 150% in 2028, and 125% in 2029. The bill provides funds for FY2025-FY2029 for the Centers for Medicare & Medicaid Services to contract with entities to provide technical assistance to primary care practices that want to adopt models for behavioral health integration.
Resolution· HRESH.Res. 276 (119th)referred
United States · United States Congress · 31 March 2025
Bill· HRH.R. 2515 (119th)referred
United States · United States Congress · 31 March 2025
American Tank Car Modernization Act of 2025 This bill establishes new Federal Railroad Administration (FRA) pilot and grant programs to outfit tank railcars with onboard sensors capable of delivering real-time safety-related condition data while a train is in motion. Specifically, the FRA must establish a grant program for freight railcar owners or operators to purchase and install (1) onboard freight railcar telematics systems (for wirelessly communicating a railcar's location and health), or (2) onboard freight railcar gateway devices (for collecting and exchanging data between railcar devices, including monitoring and telematics systems). In selecting grant recipients, the FRA must prioritize installation of these systems or devices in newly built tank railcars and by the type of load carried, starting with tank cars in TIH/PIH (toxic or poison inhalation hazard) service. In addition, the FRA must establish a pilot program to assist freight railcar owners and manufacturers in the development of onboard sensor technologies in order to add visibility to the safety of freight railcars, and encourage development of freight railcar onboard sensors that communicate to the freight railcar onboard gateway devices to offer future capabilities of real-time visibility (e.g., wheel and wheel bearing temperature).
Bill· HRH.R. 2491 (119th)referred
United States · United States Congress · 31 March 2025
Alleviating Barriers for Caregivers Act or the ABC Act This bill requires federal agencies to review and modify the administrative processes related to Medicare, Medicaid, the Children's Health Insurance Program (CHIP), and Social Security programs in order to streamline these processes for family caregivers. Specifically, the Centers for Medicare & Medicaid Services (CMS) and the Social Security Administration (SSA) must review processes related to eligibility determinations, applications, forms, and communications for these programs and identify ways to simplify and streamline these processes for family caregivers (e.g., reducing the need for family caregivers to submit the same information for multiple programs). The CMS and SSA must solicit input from family caregivers and state and regional organizations, implement any identified improvements, and report on these efforts to Congress. In addition, the CMS must issue a letter to state Medicaid and CHIP programs that encourages states to conduct a similar review and that provides potential improvements.
Bill· SS. 1164 (119th)referred
United States · United States Congress · 27 March 2025
Increasing Access to Dental Insurance Act This bill permits individuals to enroll in a dental benefits plan on a health insurance exchange without also enrolling in a qualified health plan.
Bill· SS. 1168 (119th)referred
United States · United States Congress · 27 March 2025
Portable Ultrasound Reimbursement Equity Act of 2025 This bill provides for Medicare coverage of ultrasound tests performed at a beneficiary's home. The Centers for Medicare & Medicaid Services must provide for separate payments for portable ultrasound services in the same manner and to the same extent as for portable X-ray services.
Bill· SS. 1176 (119th)referred
United States · United States Congress · 27 March 2025
Bill· SS. 1173 (119th)referred
United States · United States Congress · 27 March 2025
Restore Protections for Dialysis Patients Act This bill specifies certain requirements for private health insurers regarding coverage of individuals with end stage renal disease (ESRD) who are also covered under Medicare. In particular, the bill specifies that insurers may not limit benefits, including limiting network composition, in a manner that will affect ESRD Medicare beneficiaries differently compared to others without ESRD. The bill additionally specifies that insurers are not required to include a particular renal dialysis provider or a particular number of such providers as part of their networks.
Bill· SS. 1186 (119th)referred
United States · United States Congress · 27 March 2025
Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
Bill· HRH.R. 2436 (119th)referred
United States · United States Congress · 27 March 2025
Bill· HRH.R. 2404 (119th)referred
United States · United States Congress · 27 March 2025
Bill· HRH.R. 2477 (119th)referred
United States · United States Congress · 27 March 2025
Portable Ultrasound Reimbursement Equity Act of 2025 This bill provides for Medicare coverage of ultrasound tests performed at a beneficiary's home. The Centers for Medicare & Medicaid Services must provide for separate payments for portable ultrasound services in the same manner and to the same extent as for portable X-ray services.
Bill· HRH.R. 2433 (119th)passed
United States · United States Congress · 27 March 2025
Reducing Medically Unnecessary Delays in Care Act of 2025 This bill requires Medicare coverage decisions, including prior authorization requirements and adverse coverage decisions, to be based on written clinical criteria that is developed in consultation with physicians.
Bill· HRH.R. 2426 (119th)open
United States · United States Congress · 27 March 2025
Veterans Mental Health and Addiction Therapy Quality of Care Act This bill requires the Department of Veterans Affairs (VA) to seek to enter into an agreement with an independent and objective organization to study the difference in quality of mental health and addiction therapy care provided by the VA compared to non-VA providers across various modalities. The organization must publish its findings publicly.
Bill· HRH.R. 2450 (119th)referred
United States · United States Congress · 27 March 2025
Prescription Drug Transparency and Affordability Act This bill requires pharmacy benefit managers (PBMs) to report, at least once every six months, prescription drug pricing, payment, and utilization data to the health insurance plans for which the PBM provides services. Specifically, a PBM contracted to provide services to an employer or sponsor offering a large group health insurance plan (i.e., a plan with at least 100 employees or participants) must report to the plan certain information for prescription drug claims under the plan. This includes, for each drug, the difference between the compensation paid by the plan to the PBM and the compensation paid by the PBM to the pharmacy. Further, for each therapeutic class of drugs under the plan, a PBM must report (1) the total amount it received in rebates, fees, and discounts; and (2) the net spending for each class after such rebates, fees, and discounts. Each PBM also must report certain information about (1) drugs for which total spending exceeded $10,000; and (2) drugs dispensed through pharmacies affiliated with the plan or PBM, such as the percentage of prescriptions dispensed by such affiliates. Finally, a PBM providing services to any group health insurance plan must provide the plan with a summary document that includes similar information for prescription drug claims under the plan, as determined by the Department of Health and Human Services. Plans must also make certain aggregate summary information available to plan participants. PBMs and plans that violate these requirements are subject to civil penalties.
Bill· HRH.R. 2469 (119th)referred
United States · United States Congress · 27 March 2025
Bill· HRH.R. 2437 (119th)referred
United States · United States Congress · 27 March 2025
End-of-life Access to Supportive and Essential care Act of 2025 or the EASE Act of 2025 This bill requires hospitals to provide, as part of the hospital discharge process, patients who are eligible for hospice care under Medicare with information about providers of hospice care in their area.
Bill· HRH.R. 2471 (119th)referred
United States · United States Congress · 27 March 2025
Bill· HRH.R. 2445 (119th)referred
United States · United States Congress · 27 March 2025
Ensuring Medicaid Eligibility Act of 2025 This bill establishes additional requirements for state Medicaid programs with respect to verifying the eligibility of enrollees, particularly for noncitizens. It also prohibits federal Medicaid payment for services for certain noncitizens who are temporarily admitted into the United States. The bill prohibits implementation of the rule titled Medicaid Program; Streamlining the Medicaid, Children's Health Insurance Program, and Basic Health Program Application, Eligibility Determination, Enrollment, and Renewal Processes , which was issued by the Centers for Medicare & Medicaid Services on April 2, 2024. Specifically, the bill prohibits implementation of provisions that, among other changes, (1) allow state Medicaid programs to verify an individual’s U.S. citizenship and identity through certain systems without additional proof of identity; (2) align certain Medicaid enrollment processes for those whose eligibility is not based on income with those that are based on income; and (3) establish additional timelines for Medicaid eligibility terminations, including when there is a change in an individual’s circumstances. The bill also requires state Medicaid programs to (1) verify an individual's citizenship or immigration status prior to enrolling the individual in Medicaid; and (2) for individuals who qualify for Medicaid based on income, verify the individual's income on at least a quarterly basis while enrolled. Finally, the bill prohibits federal Medicaid payment for services provided to noncitizens granted parole, asylum, Temporary Protected Status, withholding of removal, or deferred action, including Deferred Action for Childhood Arrivals (DACA) recipients.
Bill· HRH.R. 2473 (119th)referred
United States · United States Congress · 27 March 2025
Bill· HRH.R. 2414 (119th)referred
United States · United States Congress · 27 March 2025
Bill· SS. 1157 (119th)open
United States · United States Congress · 26 March 2025
Bill· SS. 1140 (119th)referred
United States · United States Congress · 26 March 2025
Resolution· SRESS.Res. 143 (119th)passed
United States · United States Congress · 26 March 2025
This resolution designates May 29, 2025, as Mental Health Awareness in Agriculture Day to raise awareness around mental health in the agricultural industry and reduce the stigma associated with mental illness.
Resolution· SRESS.Res. 140 (119th)passed
United States · United States Congress · 26 March 2025
This resolution designates the first week of April 2025 as National Asbestos Awareness Week.
Resolution· HRESH.Res. 256 (119th)referred
United States · United States Congress · 26 March 2025
This resolution expresses support for the goals and ideals of Endometriosis Awareness Month. Endometriosis is a painful condition in which the tissue that normally lines the inside of the uterus grows outside the uterus.
Bill· HRH.R. 2372 (119th)referred
United States · United States Congress · 26 March 2025
Bill· HRH.R. 2381 (119th)referred
United States · United States Congress · 26 March 2025
Bill· HRH.R. 2387 (119th)referred
United States · United States Congress · 26 March 2025
No Harm Act This bill prohibits federal funding for sex-trait altering treatment for minors, authorizes civil actions for harm caused by such procedures, and subjects certain procedures to potential criminal penalties. The bill defines sex-trait altering treatment as generally meaning medical treatment altering the physical or physiological characteristics of an individual’s biological sex (except for treating sexual development disorders, severe injuries, or injuries caused by sex-trait altering treatments). The bill prohibits federal funds for supporting sex-trait altering treatment for minors, government regulatory action promoting such treatment, medical institutions providing such treatment, and elementary or secondary schools allowing school personnel to provide or support such treatment without parental consent. The bill prohibits discrimination against, or penalization of, providers who decline to perform such treatment. Additionally, parents of a minor have a right to decline such treatment for the minor. States that require providers to furnish such treatment, or that do not require parental consent, may not receive certain federal funds. The bill establishes a private right of action against health care providers for harm caused by such treatment or for not obtaining parental consent. It also generally establishes a private right of action against individuals or entities that violate the bill's other provisions. Finally, the bill makes changes to the existing federal criminal prohibition on performing female genital mutilation on a minor. The bill specifies that the performance of sex-altering surgery on a minor is not considered medically necessary and thus may be subject to the applicable criminal penalties.
Bill· HRH.R. 2383 (119th)referred
United States · United States Congress · 26 March 2025
Bill· SS. 1100 (119th)referred
United States · United States Congress · 25 March 2025
Nutritious SNAP Act of 2025 This bill prohibits Supplemental Nutrition Assistance Program (SNAP) benefits from being used to purchase certain beverages (e.g., soda) and snack foods. Specifically, SNAP benefits may only be used to purchase a beverage that is nonalcoholic and is (1) water, (2) cow's milk, (3) a milk-substitute beverage (e.g., almond milk, soy milk, and coconut milk), or (4) 100% juice. Further, the bill prohibits the use of benefits to purchase snack and dessert food items which are included on the Food and Nutrition Service's Accessory Foods List that went into effect on March 5, 2018. Examples of snack and dessert foods on the list include potato and tortilla chips, ice cream, candy, snack cakes and pastries, and packaged baking mixes for cakes, brownies, and muffins. In addition, on the request of a state agency, the Department of Agriculture must allow the state agency to prohibit the use of SNAP benefits to purchase food that the applicable state nutrition agency determines to be unhealthy food.
Bill· SS. 1105 (119th)referred
United States · United States Congress · 25 March 2025
No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act or the No UPCODE Act This bill modifies certain factors that are used to determine Medicare Advantage (MA) payments, particularly relating to health status and related data. Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to use two years of diagnostic data in its risk adjustment methodology for MA payments. It also prohibits the CMS from using diagnoses that are collected from chart reviews or health risk assessments when adjusting payments based on health status. The CMS must also take into account any differences in coding patterns between MA and traditional Medicare when determining MA payment adjustments.
Bill· SS. 1104 (119th)referred
United States · United States Congress · 25 March 2025
Bill· SS. 1129 (119th)referred
United States · United States Congress · 25 March 2025
Dietary Guidelines Reform Act of 2025 This bill increases the requirements for the Dietary Guidelines for Americans (DGA). The DGA are federally developed recommendations by the Department of Agriculture (USDA) and the Department of Health and Human Services (HHS). Under the bill, USDA and HHS must jointly publish guidelines at least once every 10 years (currently 5 years), and the final DGA is subject to rulemaking requirements. The DGA must be based on significant scientific agreement that is determined by evidence-based review. Current law requires that the guidelines be based on a preponderance of current scientific and medical knowledge. Further, the guidelines must address issues such as (1) high-priority areas to advance health outcomes, (2) achieving nutritional adequacy and promoting health, and (3) common nutrition-related chronic diseases. In updating the guidelines, USDA and HHS must establish an Independent Advisory Board that must submit a list of scientific questions to be used as the basis for the proposed DGA. Members of the board must (1) have expertise in nutrition science or food science, and (2) disclose all relevant financial and nonfinancial conflicts of interest. The bill prohibits the DGA from being based on or including topics that are not relevant to dietary guidance (e.g., taxation, social welfare policies, food and agricultural production practices, and race). The bill provides specified funds through FY2029 to carry out these requirements. Finally, the bill specifies that the 2020 DGA are the controlling guidelines until new guidelines are published in accordance with these requirements.
Resolution· SRESS.Res. 138 (119th)passed
United States · United States Congress · 25 March 2025
This resolution expresses support for Deep Vein Thrombosis and Pulmonary Embolism Awareness Month. Deep vein thrombosis is a condition caused by a blood clot in the deep veins of the body; pulmonary embolisms (i.e., where a blood clot breaks off and lodges in the lung) are a potentially life-threatening complication of this condition.
Bill· HRH.R. 2340 (119th)referred
United States · United States Congress · 25 March 2025
Advancing Enrollment and Reducing Drug Costs Act This bill specifies that certain Medicaid enrollees automatically qualify for low-income subsidies under the Medicare prescription drug benefit. Specifically, the bill automatically qualifies individuals who were enrolled in Medicaid before they turned 65 (as part of Medicaid expansion under the Patient Protection and Affordable Care Act) and whose income is below 200% of the federal poverty line.
Bill· HRH.R. 2319 (119th)open
United States · United States Congress · 25 March 2025
Women and Lung Cancer Research and Preventive Services Act of 2025 This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national lung cancer screening strategy and public education campaign.
Bill· HRH.R. 2326 (119th)referred
United States · United States Congress · 25 March 2025
Dietary Guidelines Reform Act of 2025 This bill increases the requirements for the Dietary Guidelines for Americans (DGA). The DGA are federally developed recommendations by the Department of Agriculture (USDA) and the Department of Health and Human Services (HHS). Under the bill, USDA and HHS must jointly publish guidelines at least once every 10 years (currently 5 years), and the final DGA is subject to rulemaking requirements. The DGA must be based on significant scientific agreement that is determined by evidence-based review. Current law requires that the guidelines be based on a preponderance of current scientific and medical knowledge. Further, the guidelines must address issues such as (1) high-priority areas to advance health outcomes, (2) achieving nutritional adequacy and promoting health, and (3) common nutrition-related chronic diseases. In updating the guidelines, USDA and HHS must establish an Independent Advisory Board that must submit a list of scientific questions to be used as the basis for the proposed DGA. Members of the board must (1) have expertise in nutrition science or food science, and (2) disclose all relevant financial and nonfinancial conflicts of interest. The bill prohibits the DGA from being based on or including topics that are not relevant to dietary guidance (e.g., taxation, social welfare policies, food and agricultural production practices, and race). The bill provides specified funds through FY2029 to carry out these requirements. Finally, the bill specifies that the 2020 DGA are the controlling guidelines until new guidelines are published in accordance with these requirements.
Bill· HRH.R. 2333 (119th)referred
United States · United States Congress · 25 March 2025
Protecting Students with Disabilities Act This bill prohibits the use of appropriated funds to eliminate the Department of Education's (ED's) oversight of the Individuals with Disabilities Education Act (IDEA). (The IDEA authorizes grant programs that support special education and early intervention services for children with disabilities. Currently, the IDEA is administered by the Office of Special Education Programs in the Office of Special Education and Rehabilitative Services in ED.) Specifically, the bill prohibits the use of appropriated funds to eliminate, consolidate, or otherwise restructure any office within ED that administers or enforces programs under the IDEA. Further, appropriated funds may not be used to (1) terminate, reassign, or alter the responsibilities of any personnel of any such office; or (2) contract with, or delegate to, any entity outside of ED to administer or enforce IDEA programs. (On March 20, 2025, President Donald Trump signed an executive order titled Improving Education Outcomes by Empowering Parents, States, and Communities , calling for the closure of ED and giving authority over education to the states. Further, the Trump Administration has announced plans to transfer ED's oversight of services for students with disabilities to the Department of Health and Human Services.)
Bill· HRH.R. 2343 (119th)referred
United States · United States Congress · 25 March 2025
John W. Walsh Alpha-1 Home Infusion Act of 2025 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
Bill· HRH.R. 2314 (119th)referred
United States · United States Congress · 25 March 2025
Fair Access In Residency Act of 2025 or the FAIR Act of 2025 This bill requires hospitals that receive graduate medical education (GME) payments under Medicare to report certain information about the composition of their medical residency training programs. Specifically, hospitals must provide to the Centers for Medicare & Medicaid Services (CMS) (1) the number of applicants for residencies who are from osteopathic medical schools and from allopathic medical schools, (2) the number of applicants who are accepted from each of these types of medical schools, and (3) an affirmation that the hospital considers applicants from each of these types of medical schools and accepts specified related examination results, as appropriate. Hospitals that do not provide this information are subject to a 2% reduction in their GME payments. The CMS must post the information it receives on a public website.
Resolution· HRESH.Res. 253 (119th)referred
United States · United States Congress · 25 March 2025
This resolution supports the designation of Prader-Willi Syndrome Awareness Day. This is a rare genetic disorder that causes a variety of symptoms, including developmental delays and extreme appetite.
Bill· HRH.R. 2339 (119th)referred
United States · United States Congress · 25 March 2025
Bill· SS. 1096 (119th)open
United States · United States Congress · 24 March 2025
Preserve Access to Affordable Generics and Biosimilars Act This bill prohibits parties from entering into any agreement that resolves or settles a patent claim related to the sale of a drug or biological product and that has anticompetitive effects. Such an agreement is presumed to have anticompetitive effects if the filer of a generic drug or biosimilar application receives anything of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biosimilar. An agreement is exempt if the only consideration granted to the generic manufacturer is (1) the right to market and secure final approval for its product prior to the expiration of any statutory exclusivity, (2) a payment for reasonable litigation expenses, or (3) a covenant not to sue on any claim that the generic drug or biosimilar infringes a U.S. patent. An agreement is also exempt if the agreement's pro-competitive benefits outweigh the anticompetitive effects. The bill provides for enforcement by the Federal Trade Commission (FTC). Violators are subject to penalties including the forfeiture of the 180-day marketing exclusivity period for a generic drug. Additionally, when a generic or biosimilar drug manufacturer enters into an agreement with another drug manufacturer related to the manufacturing, marketing, or sale of a drug, the manufacturers must certify that the material they have given the FTC and the Department of Justice concerning the agreement contains the complete agreement and any related agreements, including descriptions of any oral agreements or representations.
PreviousPage 27 of 28Next